A Phase 1/2 Study to Assess the Safety and Efficacy of OCU410ST for Stargardt Disease.
Clinical Trial Grant
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Ocugen, Inc.
Start Date
January 26, 2024
End Date
February 14, 2029
Administered By
Ophthalmology, Vitreoretinal Diseases & Surgery
Awarded By
Ocugen, Inc.
Start Date
January 26, 2024
End Date
February 14, 2029